Technical notes
GLP-1 side chains and linkers: what to specify before you send an RFQ
Most enquiries we receive for GLP-1 building blocks read something like “Fmoc-AEEA-OH, 98%, 10 kg”. That single line can return quotes that differ by 40% and materials that behave nothing alike on the resin. The four items below are small by mass and large by consequence: get their specifications wrong and you lose protected peptide in the coupling step, then fight a hydrophobic impurity through every purification.
Why the side chain decides the campaign
A GLP-1 agonist such as semaglutide or tirzepatide carries a fatty diacid tethered through a short PEG linker to a lysine side chain. The tail is what keeps the peptide in circulation: it binds albumin, slows renal clearance and turns a molecule with a half-life of minutes into one dosed weekly. Remove it and the pharmacology collapses.
The manufacturing consequence is less obvious. The tail is hydrophobic, so every impurity that carries it — a truncated sequence, a mis-coupled linker, an incompletely deprotected ester — travels with your product on reverse-phase. You cannot separate it by making the gradient shallower. Coupling efficiency at the linker therefore sets both your yield and your purification burden, and it is decided long before the peptide is assembled, when you choose the grade of the building block.
The four building blocks, and what each one does
| Building block | CAS | Role in the molecule | Specification that matters most |
|---|---|---|---|
| Fmoc-AEEA-OH | 166108-71-0 | OEG linker, used twice in semaglutide-type and tirzepatide-type side chains; separates the lipid from the peptide and improves solubility of the conjugate | Assay by HPLC at 254 nm plus the di-acid and dimer content |
| C18 diacid mono-tert-butyl ester | 843666-40-0 | Protected half-acid that becomes the lipid anchor after TFA cleavage; the free acid couples to the linker amine | Free diacid content and ester hydrolysis on storage |
| L-Pyroglutamic acid | 98-79-3 | N-terminal pGlu residue of GnRH analogues such as leuprolide; blocks aminopeptidase attack and is required for receptor binding | Optical purity (D-enantiomer) and cyclisation by-products |
| Fmoc-D-Trp-OH | 86123-11-7 | D-configured tryptophan in somatostatin analogues such as octreotide; the D-residue resists proteolysis and locks the β-turn | Chiral purity, and the D/L ratio by chiral HPLC |
Fmoc-AEEA-OH — the linker everyone buys, few specify
2-[2-(Fmoc-amino)ethoxy]ethoxyacetic acid is a commodity in the peptide world and still a frequent source of trouble. Two impurities dominate: the di-acid formed when the Fmoc group is lost and the terminal amine oxidises through to the acid, and dimeric material from incomplete coupling in the linker synthesis itself. Both are close in retention time to the product and both consume two equivalents of your precious protected peptide if they react.
C18 diacid mono-tert-butyl ester — mind the homologue
This is the C18 half-ester used in semaglutide-type side chains. Tirzepatide uses the C20 homologue, which is a different item with a different lead time; if your target is tirzepatide, say so in the enquiry rather than ordering “C18” and correcting it later. The specification to insist on is free diacid, because the diacid is difunctional and will cross-link two peptide chains. The ester is also prone to hydrolysis: a material sitting in a warm warehouse for a year is not the material on the certificate.
L-Pyroglutamic acid — bulk price, chiral specification
Widely available and priced with the amino-acid complex, which is exactly why buyers stop reading the specification. For a GnRH analogue the D-enantiomer is the impurity that matters, and it is not visible on a standard C18 method. Ask for chiral HPLC or optical rotation, and ask which one.
Fmoc-D-Trp-OH — the enantiomer you must prove
D-tryptophan is the residue that gives octreotide its stability, and the L form is the failure mode. A supplier reporting “99% HPLC” has told you nothing about the D/L ratio. Require chiral purity with the method named.
Purity is a method, not a number
“98%” on its own is not a specification. The same lot can read 98.2% or 95.6% depending on four choices the supplier makes and rarely states: detection wavelength, gradient, whether the figure is area percent or against an external standard, and whether unspecified impurities are included in the total.
For Fmoc compounds the wavelength matters more than usual. The Fmoc group absorbs strongly at 254 nm, while the peptide backbone and the linker are far better seen at 214 nm. A chromatogram run only at 254 nm can miss exactly the impurities you care about. Ask for the chromatogram, the gradient table and the wavelength — not the number.
Seven numbers that make quotes comparable
| # | Item | What to require |
|---|---|---|
| 1 | Assay | HPLC area% with wavelength, column and gradient stated |
| 2 | Chiral purity | ee or D/L ratio, method named (chiral HPLC, chiral GC or optical rotation) |
| 3 | Water | Karl Fischer, not “loss on drying” for hygroscopic Fmoc derivatives |
| 4 | Residual solvents | GC with the classes declared against ICH Q3C |
| 5 | Impurity profile | Largest single unspecified impurity plus total unspecified, with limits agreed in writing |
| 6 | Active content | Fmoc content or loading by UV titration or quantitative NMR |
| 7 | Physical form | Appearance and particle size, if the material is to be dispensed or dissolved at scale |
Two further documents decide whether the material is usable in a regulated process, and neither appears on a standard COA: a TSE/BSE statement, and a nitrosamine risk assessment for any amine-containing building block. Both are now routine requests from European and Japanese customers. A supplier who cannot produce them in a week is not a supplier for a clinical programme.
The RFQ we would send
Six lines, five minutes, and the quotes come back comparable:
1. Product, CAS, grade (e.g. Fmoc-AEEA-OH, 166108-71-0, peptide grade) 2. Quantity now, plus annual forecast and expected campaign size 3. Specification: assay + method, chiral purity + method, water, residual solvents 4. Documentation: batch-specific COA with chromatograms, MS/NMR, TSE/BSE, nitrosamine statement 5. Packaging and storage: pack size, desiccant, temperature, retest period 6. Commercial: MOQ, lead time, price validity, Incoterms, sample availability
The second line is the one buyers leave out and the one that changes the price most. A supplier quoting against a one-off 10 kg order and the same supplier quoting against a 200 kg annual programme are not the same supplier, commercially or in the quality they will assign to your account.
Sourcing notes from China
These four items sit at very different points on the supply curve, and treating them as one basket is a common mistake.
- Fmoc-AEEA-OH is made by several producers at kilogram to multi-tonne scale. Capacity is not the constraint; the spread in dimer and di-acid content between producers is, and it does not track price.
- C18 diacid mono-tert-butyl ester is a campaign product with fewer producers and longer lead times. Order against a forecast, not against a purchase order, and check the assay on arrival rather than trusting a certificate issued a year earlier.
- L-Pyroglutamic acid is bulk material whose price follows the glutamic acid chain. The differentiator is chiral purity, not availability.
- Fmoc-D-Trp-OH is a chiral resolution product; the D/L ratio and the price are directly linked. A quote well below the market is a statement about enantiomeric excess.
One structural point on documentation: these are building blocks, not active substances. If your process requires a GMP starting material under ICH Q11, or a supplier audited to a specific standard, put that in the first email. It determines which of our partner sites we quote from, and it cannot be retrofitted after the order.
How we can help
Laurand Chem supplies these four building blocks and the wider peptide linker range from qualified Chinese producers, with batch-specific documentation, chromatograms and residual-solvent data issued against your specification rather than ours. Send us the six lines above and we will return a specification sheet and a quote, or tell you plainly that the grade you need is not one we can support.
Request a quote or specification sheet
Related products: Fmoc-AEEA-OH · C18 diacid mono-tert-butyl ester · L-pyroglutamic acid · Fmoc-D-Trp-OH · Tirzepatide API